A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors

NCT05949632 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
5
Enrollment
INDUSTRY
Sponsor class

Stopped This was a strategic business decision. There were no safety concerns contributing to this decision.

Conditions

Interventions

Sponsor

Incyte Corporation